兆馳股份(002429.SZ):兆馳半導體MiniRGB芯片出貨量已達到行業最大
格隆匯7月10日丨兆馳股份(002429.SZ)披露投資者關係活動記錄表顯示,公司芯片業務目前總產能約110萬片,其中,氮化鎵芯片105萬片(4寸片),砷化鎵芯片達到5萬片(4寸片)。從產品端來看,自2021年以來,公司不斷優化產品結構,以提升公司芯片的整體價值量。自2021年起,兆馳半導體決定將其產品全體系由原先的普通照明芯片轉向更高附加值的產品領域。截至目前,兆馳半導體MiniRGB芯片出貨量已達到行業最大,並已成功轉型為以高毛利照明、背光、顯示等高附加值芯片為主要投放的芯片廠商。
同時,公司不斷推行新的技術降本路徑,公司芯片盈利能力大幅度上升。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.